APA (7th ed.) Citation

R, A., P, V., S, R., V, K., R, K., B, L., . . . S, S. (2024). Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen. Human vaccines & immunotherapeutics, 20(1), 2351664. https://doi.org/10.1080/21645515.2024.2351664

Chicago Style (17th ed.) Citation

R, Ahuja, et al. "Characterization and Immunogenicity Assessment of MERS-CoV Pre-fusion Spike Trimeric Oligomers as Vaccine Immunogen." Human Vaccines & Immunotherapeutics 20, no. 1 (2024): 2351664. https://doi.org/10.1080/21645515.2024.2351664.

MLA (9th ed.) Citation

R, Ahuja, et al. "Characterization and Immunogenicity Assessment of MERS-CoV Pre-fusion Spike Trimeric Oligomers as Vaccine Immunogen." Human Vaccines & Immunotherapeutics, vol. 20, no. 1, 2024, p. 2351664, https://doi.org/10.1080/21645515.2024.2351664.